CasLoc logo
All Cases PTAB Litigations UPC Oppositions

AbbVie Inc. v. Hetero USA Inc.

1:15-cv-00889

Overview

Case Number 1:15-cv-00889
Filing Date 2015-10-02
Status Terminated
Termination Date 2015-10-27
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Hetero Labs Limited Unit-III NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

AbbVie Inc. Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Plaintiff

Abbvie Deutschland GMBH & Co. KG Operating Company

Represented By

3 Attorneys Listed

Derek James Fahnestock

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Mary B. Graham

Morris, Nichols, Arsht & Tunnell LLP

Tel: +1 (302) 658-9200

1201 North Market Street, P.O. Box 1347

Stephen J. Kraftschik

Polsinelli PC

Tel: +1 (302) 252-0926
Fax: +1 (302) 252-0921

222 Delaware Avenue, Suite 1101, Wilmington, DE 19801

Counter Claimant

Hetero Labs Limited NPE (University / Research)

Represented By

0 Attorneys Listed
No attorneys available

Hetero USA Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 5 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 9 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (5): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (9 found):
U.S. Courts: 9
U.S. District Court 2017-01-13
1:17-cv-00047

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2016-05-27
1:16-cv-00398

AbbVie Inc. v. Amneal Pharmaceuticals, LLC

Asserted Patent
Status: DED
U.S. District Court 2014-09-25
1:14-cv-01236

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

U.S. Family Sibling (["US8691878"])
Status: DED
U.S. District Court 2014-09-05
1:14-cv-01137

AbbVie Inc. v. Hetero Labs Limited

U.S. Family Sibling (["US8691878"])
Status: DED
U.S. District Court 2014-07-18
1:14-cv-00959

AbbVie Inc. v. Aurobindo Pharma Limited

Asserted Patent
Status: DED
U.S. District Court 2013-07-03
2:13-cv-00645

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: OHSD
U.S. District Court 2013-06-14
1:13-cv-01072

AbbVie Inc. v. Mylan Pharmaceuticals Inc.

Asserted Patent
Status: DED
U.S. District Court 2013-05-15
1:13-cv-00852

AbbVie Inc. v. Hetero USA Inc.

Asserted Patent
Status: DED
U.S. District Court 2012-04-10
1:12-cv-00457

AbbVie Inc. v. Roxane Laboratories Inc.

Asserted Patent
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

11 Patents

There are 11 patents involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6037157
Method for improving pharmacokinetics
Filed: 1996-06-26
Issued: 2000-03-14
Expired (Term Ended)
Expires: 2016-06-26
US6703403
Method for improving pharmacokinetics
Filed: 2001-09-20
Issued: 2004-03-09
Expired (Term Ended)
Expires: 2016-09-09
US7148359
Polymorph of a pharmaceutical
Filed: 2005-05-04
Issued: 2006-12-12
Expired (Term Ended)
Expires: 2025-05-04
US7364752
Solid dispersion pharamaceutical formulations
Filed: 2000-11-10
Issued: 2008-04-29
Expired (Term Ended) +688d PTA
Expires: 2022-09-29
US8025899
Solid pharmaceutical dosage form
Filed: 2004-08-25
Issued: 2011-09-27
Active (1.1 yrs remaining) +1206d PTA
Expires: 2027-12-14

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(14 total)
Pleading / Complaint

COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1799572.) - filed by AbbVie Inc., Abbvie Deutschland GMBH & Co. KG. (Attachments: # 1 Exhibit A-K, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/05/2015)

Entry #1 • 2015-10-02
1
Pleading / Complaint

COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1799572.) - filed by AbbVie Inc., Abbvie Deutschland GMBH & Co. KG. (Attachments: # 1 Exhibit A-K, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/05/2015)

Entry #1 • 2015-10-02
2
Pleading / Complaint

COMPLAINT filed against Hetero Labs Limited, Hetero Labs Limited Unit-III, Hetero USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1799572.) - filed by AbbVie Inc., Abbvie Deutschland GMBH & Co. KG. (Attachments: # 1 Exhibit A-K, # 2 Civil Cover Sheet)(dmp, ) (Entered: 10/05/2015)

Entry #1 • 2015-10-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 10/05/2015)

Entry #2 • 2015-10-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: SEE ATTACHED FORM. Date of Expiration of Patent: SEE ATTACHED FORM. (dmp, ) (Entered: 10/05/2015)

Entry #3 • 2015-10-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc